Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report issued on Friday morning. Several other research firms also recently weighed in on UTHR. LADENBURG THALM/SH SH lowered their price objective on shares of United Therapeutics from $285.00 to $256.00 in a report on […]
Victory Capital Management Inc. increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 32.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,671 shares of the biotechnology company’s stock after acquiring an additional 7,046 shares during […]
The following discussion should be read in conjunction with our consolidated financial statements and related notes to our consolidated financial statements. All statements in this filing are made as of the date this Report is filed with the U.S. Securities and Exchange Commission. These statements, which are based on our beliefs and expectations about...
SAN FRANCISCO, Feb. 10, 2022 /PRNewswire/ -- The global pulmonary arterial hypertension market size is anticipated to reach USD 11.0 billion by 2030, according to a new report by Grand View
/PRNewswire/ -- The global pulmonary arterial hypertension market size is anticipated to reach USD 11.0 billion by 2030, according to a new report by Grand...